Advertisement

ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma

  • Hiroshi Okumura
  • Masahiro Noda
  • Shoji Natsugoe
ASO Author Reflections
  • 30 Downloads

Notes

Disclosure

The authors have no conflicts of interest to disclose.

References

  1. 1.
    Okumura H, Uchikado Y, Omoto I, et al. The usefulness of neoadjuvant chemoradiation therapy for locally advanced esophageal cancer with multiple lymph-node metastases. Ann Surg Oncol. 2014;21:2845–49.CrossRefGoogle Scholar
  2. 2.
    Okumura H, Uchikado Y, Setoyama T, et al. Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy. Surg Today. 2014;44:421–28.CrossRefGoogle Scholar
  3. 3.
    Noda M, Okumura H, Uchikado Y, et al. Correlation between biomarker candidate proteins with the effect of neoadjuvant chemoradiation therapy on esophageal squamous cell carcinoma. Ann Surg Oncol. 2018;25(2):449–55.  https://doi.org/10.1245/s10434-017-6271-y.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Hiroshi Okumura
    • 1
  • Masahiro Noda
    • 1
  • Shoji Natsugoe
    • 1
  1. 1.Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical SciencesKagoshima UniversityKagoshimaJapan

Personalised recommendations